Galmed Pharmaceuticals has a total of 207 patents globally, out of which 115 have been granted. Of these 207 patents, 41% patents are active. The United States of America is where Galmed Pharmaceuticals has filed the maximum number of patents, followed by Israel and Canada. Parallelly, United States of America & Israel seems to be the main focused R&D centre and also Israel is the origin country of Galmed Pharmaceuticals.
Galmed Pharmaceuticals was founded in 2000. Galmed Pharmaceuticals is a biopharmaceutical company focused on developing Aramchol. Originally aimed at treating liver diseases like NASH and PSC, Aramchol was also explored for other fibro-inflammatory conditions. The company is now working to advance Aramchol for oncology-related indications beyond liver fibrosis and NASH.
The company recently received a new South Korean patent covering the combination of Aramchol with Resmetirom (Rezdiffra) for treating MASH and liver fibrosis. This expands the company’s global IP protection and supports its strategic efforts to advance Aramchol-based combination therapies.
Keep track of every patent move and monitor competitor activity in real-time. Click here for full insights:
Do read about some of the most popular patents of Galmed Pharmaceuticals which have been covered by us in this article and also you can find Galmed Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Galmed Pharmaceuticals patent portfolio.
How many patents does Galmed Pharmaceuticals have?
Galmed Pharmaceuticals has a total of 207 patents globally. These patents belong to 19 unique patent families. Out of 207 patents, 86 patents are active.
How Many Patents did Galmed Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Galmed Pharmaceuticals Applications Filed | Galmed Pharmaceuticals Patents Granted |
| 2025 | 1 | 9 |
| 2024 | 1 | 5 |
| 2023 | 1 | 16 |
| 2022 | 2 | 3 |
| 2021 | 8 | 8 |
| 2020 | 4 | 5 |
| 2019 | 28 | 19 |
| 2018 | 2 | – |
| 2017 | 41 | – |
| 2016 | 8 | 2 |
How many Galmed Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did Galmed Pharmaceuticals File in Different Countries?
Countries in which Galmed Pharmaceuticals Filed Patents
| Country | Patents |
| United States of America | 20 |
| Israel | 17 |
| Canada | 14 |
| Australia | 13 |
| China | 13 |
| Europe (EPO) | 12 |
| Japan | 11 |
| Hong Kong (S.A.R.) | 8 |
| Germany | 8 |
| Mexico | 8 |
| Italy | 7 |
| Brazil | 7 |
| Korea (South) | 7 |
| Austria | 5 |
| India | 4 |
| Poland | 4 |
| Spain | 3 |
| Norway | 3 |
| Hungary | 3 |
| Denmark | 3 |
| Czech Republic | 3 |
| Portugal | 3 |
| Indonesia | 3 |
| Cyprus | 2 |
| Macao | 1 |
| Serbia | 1 |
| Malta | 1 |
| Estonia | 1 |
| Slovenia | 1 |
| Albania | 1 |
| Croatia | 1 |
| Slovakia | 1 |
| Turkey | 1 |
| Lithuania | 1 |
| Ukraine | 1 |
| Eurasia | 1 |
| New Zealand | 1 |
Where are Research Centers of Galmed Pharmaceuticals Patents Located?
10 Best Galmed Pharmaceuticals Patents
US7501403B2 is the most popular patent in the Galmed Pharmaceuticals portfolio. It has received 28 citations so far from companies like Catabasis Pharmaceuticals, Gannex Pharma.
Below is the list of 10 most cited patents of Galmed Pharmaceuticals:
| Publication Number | Citation Count |
| US7501403B2 | 28 |
| US8110564B2 | 26 |
| WO2018087599A1 | 24 |
| US20120157419A1 | 22 |
| WO2015083164A1 | 20 |
| US8975246B2 | 18 |
| WO2010086864A1 | 17 |
| WO2017125929A1 | 15 |
| WO2017017677A1 | 11 |
| US20160304553A1 | 11 |
Interested in knowing about Galmed Pharmaceuticals Drug Patents Expiring in the next 10 years?
What Percentage of Galmed Pharmaceuticals US Patent Applications were Granted?
Galmed Pharmaceuticals (Excluding its subsidiaries) has filed 21 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 10 have been granted leading to a grant rate of 52.63%.
Below are the key stats of Galmed Pharmaceuticals patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Galmed Pharmaceuticals?
| Law Firm | Total Applications | Success Rate |
| Pearl Cohen Zedek Latzer Baratz Llp | 19 | 58.82% |
| Vorys Sater Seymour And Pease Llp | 2 | 0% |
What are Galmed Pharmaceuticals key innovation segments?
What Technologies are Covered by Galmed Pharmaceuticals?
The chart below distributes patents filed by Galmed Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Galmed Pharmaceuticals thinks it’s important to protect particular technological inventions.
R&D Focus: How has Galmed Pharmaceuticals search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Galmed Pharmaceuticals?
